You have no items in your shopping cart.
Description
Research Area
Product Categories/Antibodies,Epigenetics,Product Categories/Research Area,Product Categories/Products/Antibodies,oncology; autoimmunity; biosimilar
Images & Validation
−| Tested Applications | Blocking, FC, IP |
|---|---|
| Reactivity | Human, Primate |
Key Properties
−| Host | Human |
|---|---|
| Clonality | Monoclonal |
| Isotype | Human IgG |
| Clone No. | hL22 (Epratuzumab) |
| Immunogen | This antibody was prepared by the humanization of LL2 (EPB-2), a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5–10% of the molecule, with the remainder being human framework sequences, which greatly reduces the potential for immunogenicity (Traczewski, 2010). |
| Target | CD22 |
| Purity | Purified |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| Buffer/Preservatives | PBS with 0.02% Proclin 300. |
| Concentration | 1 mg/ml |
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Leu14; B-cell receptor CD22; B-lymphocyte cell adhesion molecule; BL-CAM; Sialic acid-binding Ig-like lectin 2; Siglec-2; T-cell surface antigen Leu-14
Similar Products
−Anti-CD22 [hL22 (Epratuzumab)] [orb411593]
Blocking, FC, IP
Human, Primate
Human
Monoclonal
Unconjugated
0.2 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Quick Database Links
Gene Symbol
CD22
UniProt
UniProt Details
− No UniProt data available
Protocol Information
FC
Flow Cytometry
IP
Immunoprecipitation
![Anti-CD22 [hL22 (Epratuzumab)]](/images/pub/media/catalog/product/NewWebsite/35/orb411594_1.png)
![Anti-CD22 [hL22 (Epratuzumab)]](/images/pub/media/catalog/product/NewWebsite/35/orb411594_2.png)
![Anti-CD22 [hL22 (Epratuzumab)]](/images/pub/media/catalog/product/NewWebsite/35/orb411594_3.png)
![Anti-CD22 [hL22 (Epratuzumab)]](/images/pub/media/catalog/product/NewWebsite/35/orb411593_1.png)
![Anti-CD22 [hL22 (Epratuzumab)]](/images/pub/media/catalog/product/NewWebsite/35/orb411593_2.png)
![Anti-CD22 [hL22 (Epratuzumab)]](/images/pub/media/catalog/product/NewWebsite/35/orb411593_3.png)